TCINO BIOSCIENCE

tcino-bioscience-logo

Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.

#SimilarOrganizations #Financial #Website #More

TCINO BIOSCIENCE

Social Links:

Industry:
Biotechnology Medical Test And Measurement

Founded:
2020-09-02

Address:
Yongin, Ch'ungch'ong-namdo, South Korea

Country:
South Korea

Website Url:
http://www.txinno.com

Total Employee:
11+

Status:
Active

Contact:
+82 82 31 778 8688

Email Addresses:
[email protected]

Total Funding:
9.2 B KRW

Technology used in webpage:
South Korean Server Location


Similar Organizations

adept-biopharma-logo

Adept Biopharma

Adept Biopharma develops innovative immuno-therapeutics to help cancer patients.

enkang-pharmaceutical-technology-logo

Enkang Pharmaceutical Technology

Enkang Pharmaceutical Technology develops innovative new anti-cancer drugs and pharmaceutical products.

excelmab-logo

ExcelMab

ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.

glyconex-logo

GlycoNex

GlycoNex develops and licenses anti-cancer monoclonal antibodies.

synrx-therapeutics-logo

SynRx Therapeutics

SynRx Therapeutics develops novel anti-cancer agents.

Investors List

dayli-partners_image

Dayli Partners

Dayli Partners investment in Venture Round - Tcino Bioscience

company-k_image

Company K Partners

Company K Partners investment in Venture Round - Tcino Bioscience

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Series A - Tcino Bioscience

schmidt-4d8d_image

Schmidt

Schmidt investment in Series A - Tcino Bioscience

dsc-investment_image

DSC Investment

DSC Investment investment in Series A - Tcino Bioscience

company-k_image

Company K Partners

Company K Partners investment in Series A - Tcino Bioscience

schmidt-4d8d_image

Schmidt

Schmidt investment in Seed Round - Tcino Bioscience

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Seed Round - Tcino Bioscience

dsc-investment_image

DSC Investment

DSC Investment investment in Seed Round - Tcino Bioscience

tips-program_image

TIPS Program

TIPS Program investment in Pre Seed Round - Tcino Bioscience

Official Site Inspections

http://www.txinno.com Semrush global rank: 13.5 M Semrush visits lastest month: 78

  • Host name: 218.232.108.237
  • IP address: 218.232.108.237
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Tcino Bioscience"

Txinno Bioscience Inc.

Pursuing innovative treatments; Bringing hope and joy to patients and their families; A dedicated company developing novel small molecule therapies for cancerSee details»

Tcino Bioscience - Crunchbase Company Profile

Organization. Tcino Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email โ€ฆSee details»

TxinnoBioscience Inc. - Medical XPRT

Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform โ€ฆSee details»

Txinno

์น˜๋ฃŒ์— ํ˜์‹ ์„ ๋”ํ•ด; ์•”ํ™˜์ž์™€ ํ™˜์ž๊ฐ€์กฑ์—๊ฒŒ ํฌ๋ง๊ณผ ํ–‰๋ณต์„ ์ฃผ๋Š”; ์ €๋ถ„์ž ํ˜์‹ ํ•ญ์•”์ œ ๊ฐœ๋ฐœ ์ „๋ฌธ๊ธฐ์—…See details»

Txinno Bioscience - PitchBook

Txinno Bioscience General Information Description. Operator of a biotech company designed to discover new drugs. The company secures and builds core platform technologies such as โ€ฆSee details»

Companext

Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform โ€ฆSee details»

Txinno Bioscience Co., Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Txinno Bioscience Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Technology Platform ...See details»

TXINNO Bioscience Inc | VentureRadar

Txinno Bioscience Inc. is a dedicated company focused on developing novel small molecule therapies for cancer. By targeting the innate immune RAS pathway, Txinno aims to create โ€ฆSee details»

TXINNO Bioscience Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for TXINNO Bioscience Inc of Yongin, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»

TXINNO Bioscience - Overview, News & Similar companies

TXINNO Bioscience Inc is a company that operates in the Pharmaceuticals industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in ์ƒํ˜„๋™, ๊ฒฝ๊ธฐ๋„, โ€ฆSee details»

Txinno - Company Profile - Tracxn

Txinno - Developer of therapeutics for the treatment of cancer. Raised a total funding of $8.5M over 1 round from 4 investors. Founded by Chan-Sun Park and Seongjun Kim in the year โ€ฆSee details»

Txinno Bioscience Inc. - VentureRadar

Similar Companies: RDP Pharma Unknown n/a RDP Pharma (RDP) is a privately held biotech, dedicated to the vision that their products will deliver valuable medicines to patients in need. โ€ฆSee details»

2 Key words of Txinno Bio..โ€œOrally available STING agonist & RAS ...

Apr 12, 2021 Txinno Bio was established in September of last year. In the same year, it attracted a total of 2.55 billion won worth of investment from Schmidt, Korea Investment Partners, and โ€ฆSee details»

TXINNO Bioscience - Products, Competitors, Financials, Employees ...

TXINNO Bioscience specializes in the development of innovative low-molecular-weight cancer therapeutics in the biotechnology sector. The company's main offerings include targeted โ€ฆSee details»

Seed Round - Tcino Bioscience - 2021-07-16 - Crunchbase

Jul 16, 2021 Organization Name . Tcino Bioscience . Announced Date Jul 16, 2021; Closed On Date Jul 16, 2021; Funding Type Seed; Funding ... DSC Investment โ€” Recent News. Edit โ€ฆSee details»

Txinno - Raised $8.5M Funding from 4 investors - Tracxn

Txinno has raised a total funding of $8.5M over 1 round from 4 investors. Investors include Korea Investment Holdings, DSC Investment and 2 others. Their latest funding round was of $5.95M โ€ฆSee details»

ํ‹ฐ์”จ๋…ธ๋ฐ”์ด์˜ค, CFO์— ์ž„๊ธฐํƒœ ์ƒ๋ฌด ์˜์ž… - ๋ฐ”์ด์˜ค์ŠคํŽ™ํ…Œ์ดํ„ฐ

Dec 13, 2023 ํ‹ฐ์”จ๋…ธ๋ฐ”์ด์˜ค์‚ฌ์ด์–ธ์Šค(Txinno Bioscience)๋Š” ์ตœ๊ณ ์žฌ๋ฌด๊ด€๋ฆฌ์ž(CFO) ๊ฒธ ๊ฒฝ์˜๊ธฐํš๋ณธ๋ถ€์žฅ์œผ๋กœ ์ž„๊ธฐํƒœ ์ƒ๋ฌด๋ฅผ ์‹ ๊ทœ ์˜์ž…ํ–ˆ๋‹ค๊ณ  13์ผ ๋ฐํ˜”๋‹ค. ์ž„๊ธฐํƒœ CFO๋Š” ๋™๊ตญ๋Œ€์—์„œ โ€ฆSee details»

Txinno Bioscience Co., Ltd. (Txinno Bioscience Co., Ltd.) - ่ฏ็‰ฉ็ฎก โ€ฆ

้กนไธŽ Txinno Bioscience Co., Ltd. ็›ธๅ…ณ็š„ไธดๅบŠ่ฏ•้ชŒ NCT05978492 / Recruiting ไธดๅบŠ1ๆœŸ A Multicenter, Open-label, Phase 1 Dose Escalation and Expansion Study of TXN10128, an โ€ฆSee details»

Working at Txinno Bioscience - Glassdoor

See what employees say it's like to work at Txinno Bioscience. Salaries, reviews, and more - all posted by employees working at Txinno Bioscience.See details»

linkstock.net © 2022. All rights reserved